Related Experiment Video
Updated: Jul 15, 2026

Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples
Published on: December 2, 2022
Cells lacking DNA topoisomerase II beta are resistant to genistein
Miguel López-Lazaro1, Elaine Willmore, Caroline A Austin
1Institute for Cell and Molecular Biosciences, The Medical School, University of Newcastle-upon-Tyne, Newcastle-upon-Tyne, NE2 4HH, United Kingdom.
Abstract:
Evidence suggests that DNA topoisomerases (topos) may be involved in the anticancer and carcinogenic properties attributed to flavonoids. Using the cell-based assay TARDIS, the dietary flavonoids genistein (1) and luteolin (2) have been evaluated as topo I and topo II poisons and catalytic inhibitors in K562 leukemia cells. Both flavonoids induced topo II-DNA complexes, but they did not induce significant levels of topo I-DNA complexes. Genistein decreased the topo II-DNA complexes induced by the topo II poison etoposide, suggestive of a catalytic inhibition of topo II, and luteolin decreased the topo I-DNA complexes induced by the topo I poison camptothecin, indicative of a catalytic inhibition of topo I. Murine transgenic cells lacking topo II beta were resistant to genistein-induced cell growth inhibition (XTT assays) and cytotoxicity (clonogenic assay). High levels of topo II beta-DNA complexes were also observed in K562 cells exposed to genistein. These data suggest that topo II beta has an important function in genistein-induced cell growth inhibition and cell death. The possible role of topoisomerases in the putative anticancer and carcinogenic properties of genistein and luteolin is discussed.
Insights
Dietary flavonoids genistein and luteolin impact DNA topoisomerases (topos). Genistein inhibits topoisomerase II (topo II), while luteolin inhibits topoisomerase I (topo I), suggesting roles in anticancer and carcinogenic effects.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Flavonoids possess potential anticancer and carcinogenic properties.
- DNA topoisomerases (topos) are implicated in these effects.
- Genistein and luteolin are dietary flavonoids of interest.
Purpose of the Study:
- To evaluate genistein and luteolin as DNA topoisomerase I (topo I) and topoisomerase II (topo II) poisons and catalytic inhibitors.
- To investigate the role of topo II beta in genistein's cellular effects.
Main Methods:
- Utilized the TARDIS cell-based assay in K562 leukemia cells.
- Assessed topo I and topo II DNA complex formation.
- Employed XTT and clonogenic assays to measure cell growth inhibition and cytotoxicity.
- Examined genistein's effects in murine cells lacking topo II beta.
Main Results:
- Genistein and luteolin induced topo II-DNA complexes, but not significant topo I-DNA complexes.
- Genistein catalytically inhibited topo II, while luteolin inhibited topo I.
- Cells lacking topo II beta were resistant to genistein's growth inhibition and cytotoxicity.
- Genistein exposure led to high levels of topo II beta-DNA complexes.
Conclusions:
- Topoisomerase II beta plays a crucial role in genistein-induced cell growth inhibition and death.
- The study elucidates mechanisms by which genistein and luteolin interact with topoisomerases.
- Findings contribute to understanding the dual role of flavonoids in cancer and carcinogenicity.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Treatment Resistant Cancers
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

